Glaxo to market bird flu vaccine. UK drugs firm GlaxoSmithKline has won European Union approval for its vaccine designed to protect people against the H5N1 strain of bird flu. The ruling makes Prepandrix the first vaccine to receive a licence for use in the 27-member region. [News Source]

Brussels gives green light to Glaxo’s bird flu vaccine. Preparations to protect humans against a possible future bird flu pandemic will receive a boost today after GlaxoSmith-Kline became the first drug manufacturer to be granted marketing approval for its pre-pandemic influenza vaccine. [News Source]

EU clears Glaxo’s bird-flu vaccine. GlaxoSmithKline PLC said its Prepandrix vaccine, which could provide protection against the H5N1 bird-flu virus in advance of a potential pandemic, was cleared for use in the European Union. [News Source]

States bordering Bangladesh vulnerable to bird flu (Calcutta News) Indian states bordering Bangladesh have become vulnerable to bird flu with the country continuing to be a breeding ground for the disease, officials here said Monday. [News Source]

Siberian birds test positive for bird flu antibodies (Russian Information Agency Novosti) NOVOSIBIRSK, May 19 (RIA Novosti) - Agricultural experts have detected bird flu antibodies in migratory birds in southern Siberia, Russia's agricultural watchdog said in a statement Monday. [News Source]

States bordering Bangladesh vulnerable to bird flu (New Kerala) Agartala, May 19 : Indian states bordering Bangladesh have become vulnerable to bird flu with the country continuing to be a breeding ground for the disease, officials here said Monday. [News Source]

EU Approves GSK’s Pre-Pandemic Bird Flu Vaccine (Medical News Today) Global pharmaceutical company GlaxoSmithKline (GSK) is the first to get the go ahead for a wide spectrum vaccine to protect humans ahead of a possible future bird flu pandemic now that the European Commission (EC) is giving the drug giant approval today, Monday, to market its pre-pandemic vac [News Source]

Bird Flu Pandemic Would Require Multi-Drug Approach, UK (Medical News Today) Scientists have uncovered a change in the H5N1 bird flu virus which makes it resistant to the anti-viral drug Tamiflu. The mutation in the N1 component was found in human cases of the disease and suggests that a single drug approach is likely to be ineffective in case of a bird flu pandemic in humans. [News Source]

EU approves Glaxo bird flu vaccine (CNN.com) LONDON, England (AP) -- GlaxoSmithKline PLC said Monday that it has received permission from European medical regulators to market a human bird flu vaccine it has already sold to several governments to stockpile in preparation for a pandemic. [News Source]

First EU licence granted for pre-pandemic bird flu vaccine: GSK (AFP via Yahoo! News) The European Commission has granted the first licence to market a vaccine in preparation for a pandemic of H5N1 bird flu in Europe, British pharmaceutical firm GlaxoSmithKline said on Monday. [News Source]